Hilltop Holdings’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Hilltop Holdings’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-16,029	Closed	-$825K	–	440
2017 Q4	$825K	Sell	16,029 -9,654	-38%	-$496K	0.19%	145
2017 Q3	$1.34M	Buy	25,683 +9,654	+60%	+$496K	0.41%	80
2017 Q2	$829K	Hold	16,029	–	–	0.24%	128
2017 Q1	$806K	Hold	16,029	–	–	0.24%	127
2016 Q4	$756K	Hold	16,029	–	–	0.24%	132
2016 Q3	$798K	Hold	16,029	–	–	0.25%	136
2016 Q2	$771K	Hold	16,029	–	–	0.25%	130
2016 Q1	$732K	Hold	16,029	–	–	0.23%	140
2015 Q4	$864K	Hold	16,029	–	–	0.25%	126
2015 Q3	$791K	Sell	16,029 -3,411	-18%	-$196K	0.23%	135
2015 Q2	$1.13M	Buy	19,440 +3,411	+21%	+$199K	0.31%	112
2015 Q1	$921K	Buy	+16,029	New	+$877K	0.24%	138

Other funds holding IHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Hilltop Holdings's IHE Position: Q1 2018 in Review

Hilltop Holdings sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2018, closing a stake of 16,029 shares — an estimated $825K sold.

Hilltop Holdings first reported a position in IHE in Q1 2015 and held it in 12 quarters. The position peaked at $1.34M in Q3 2017. 101 funds tracked by Wall St. Rank hold IHE as of Q1 2018.

Hilltop Holdings reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2018 after selling out during the quarter.
Hilltop Holdings sold 16,029 iShares US Pharmaceuticals ETF shares in Q1 2018, an estimated $825K.
Hilltop Holdings first reported a position in iShares US Pharmaceuticals ETF in Q1 2015 and held it in 12 quarters.
Hilltop Holdings's iShares US Pharmaceuticals ETF position peaked at $1.34M in Q3 2017.
101 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2018.

Based on Hilltop Holdings's 13F filing for Q1 2018, filed 15 May 2018.